AREV Life Sciences Global Corp. AREVF
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.01 Day range 0.01
0.0005 52-week range 0.01
- YTD
- 0.00%
- 1 year
- -95.00%
- Market cap
- 15.88K
- YTD return
- 0.00%
- 1-year return
- -95.00%
- Volume
- 10.00K
- Open
- 0.01
- Previous close
- 0.0005
- Day's range
- 0.01 – 0.01
- 52-week range
- 0.0005 – 0.01
2Y -0.0095 (-95.00%)
News
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB 
AREV Announces Brian Cameron as Chief Financial Officer 
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB 
Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN™, a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation 
AREV Annual and Special General Meeting Results 
AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subsidiary, AREV Life Sciences, Inc. 
AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins For Use in Its Ready-To-Use Therapeutic Foods 
AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock 
AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board 
AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs
Your note
Sign in to keep a note on AREVF — it syncs with the Stock Master app.